Gasotransmitters such as NO, H2S, and CO have
emerged
as key players in the regulation of various pathophysiological functions,
prompting the development of gas therapy for various pathogeneses.
Deficient production of gasotransmitters has been linked to various
diseases such as hypertension, endothelial dysfunction, myocardial
infarction, ischemia, and impaired wound healing, as they are involved
in the regulatory action of angiogenesis. A better understanding of
the regulatory mechanisms has given new hope to address the vascular
impairment caused by the breakthroughs in gasotransmitters as therapeutics.
However, the unstable nature and poor target specificity of gas donors
limit the full efficacy of drugs. In this regard, biomaterials that
possess excellent biocompatibility and porosity are ideal drug carriers
to deliver the gas transmitters in a tunable manner for therapeutic
angiogenesis. This review article provides a comprehensive discussion
of biomaterial-based gasotransmitter delivery approaches for therapeutic
angiogenesis. The critical role of gasotransmitters in modulating
angiogenesis during tissue repair as well as their challenges and
future directions are demonstrated.